SureTrader Advertisement PRTC
Home > Boards > US OTC > Biotechs >

Galectin Therapeutics Inc. (GALT)

Add GALT Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 5/27/2016 1:38:47 PM - Followers: 43 - Board type: Free - Posts Today: 0

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function.

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources.

Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy.

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Though we do not have any current marketed products, our research and development programs, designed to ultimately help patients and their physicians, are focused on:




Fibrosis is the development of excess fibrous connective tissue in an organ when exposed to a chronic disease. The longer the disease affects the organ, the more fibrous tissue is deposited and this ultimately results in the failure of the organ. Galectin Therapeutics’ drug candidates provide a promising and exciting new approach for the treatment of fibrotic diseases, including liver, lung and kidney fibrosis. Significant unmet need exists for treatment options in fibrosis. For example, there are currently no approved medical treatments available for the millions of patients in the U.S. who have non-alcoholic steatohepatitis with advanced fibrosis – commonly known as fatty liver disease. Learn about fibrosis and our research in this area including galectin effects on liver fibrosis, lung fibrosis and kidney fibrosis.




Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of tissue called tumors. Research shows the potential for galectin inhibition to play an important role in cancer therapy, particularly tumor immunotherapy – an emerging treatment that enhances the activity of the immune system against cancer cells. There are more than 100 types of cancers, and for many of these cancers, few treatment options exist. Our drug candidates provide a new and complimentary approach to other drugs on the market for the treatment of cancer. Learn more about cancer and immunotherapy.


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
GALT News: Confidential Treatment Order (ct Order) 05/27/2016 01:01:29 PM
GALT News: Current Report Filing (8-k) 05/16/2016 04:06:35 PM
GALT News: Galectin Therapeutics Announces Positive Interim Results from Phase 2a Trial with GR-MD-02 in Moderate-to-Severe Plaque Psori... 05/16/2016 04:05:00 PM
GALT News: Galectin Therapeutics Announces Complete Enrollment in its Phase 2 Trial with GR-MD-02 in NASH Patients with Advanced Fibrosi... 05/11/2016 08:00:00 AM
GALT News: Current Report Filing (8-k) 05/11/2016 07:52:34 AM
#2177   Anybody got an idea as to the kind thefamilyman 05/27/16 01:38:47 PM
#2176   New SEC filing. Very interesting... thefamilyman 05/27/16 01:24:02 PM
#2175   In previous posts (sparse) I have implied that JERZYATP1 05/25/16 05:22:29 PM
#2174   That's an interesting perspective on where the drug biotech2010 05/23/16 03:13:23 PM
#2173   Thanks for referencing the article in -- JERZYATP1 05/20/16 10:03:46 PM
#2172   Best article about GALT I've ever read: biotech2010 05/20/16 10:14:43 AM
#2171   The PASI of 75% decline was not reached DirectionalDriller 05/17/16 08:43:16 PM
#2170   Only 0.07 up???? Coolec78 05/17/16 12:32:27 PM
#2169   Notes from the conference call: biotech2010 05/17/16 09:38:21 AM
#2168   I would really encourage all GALT shareholders to biotech2010 05/17/16 07:35:33 AM
#2167   I believe it's Dr. Ritchie. Not Richie. rickyricks 05/16/16 11:18:24 PM
#2166   You are really missing the point in these biotech2010 05/16/16 08:56:37 PM
#2165   Looks like they might have a call tomorrow Darwinian 05/16/16 08:38:17 PM
#2164   positive results on psoriasis trial... oldsport 05/16/16 05:39:56 PM
#2163   The company has been in limbo for quite biotech2010 05/11/16 08:52:10 AM
#2162   They should have lots of data by now DirectionalDriller 05/10/16 07:09:33 PM
#2161   When I saw that a couple of weeks thefamilyman 05/10/16 03:45:51 PM
#2160   They obviously have some of the data and biotech2010 05/10/16 03:34:59 PM
#2159   i agree... the stock is up 8% on oldsport 05/10/16 02:42:26 PM
#2158   "GR-MD-02 in patients with moderate-to-severe plaque psoriasis. We DirectionalDriller 05/10/16 10:22:24 AM
#2157   Earnings reports for a company without revenue are biotech2010 05/10/16 08:35:19 AM
#2156   omg... earnings s gonna be a blowout... cant wait... oldsport 05/10/16 02:43:30 AM
#2155   I saw a tweet over the weekend that jmh0602 05/09/16 08:34:02 PM
#2154   Earnings were supposed to come out before the mumble 05/09/16 07:59:31 PM
#2153   That GALT is on the right track is JERZYATP1 05/05/16 03:59:06 PM
#2152   More evidence that GALT is on the right biotech2010 05/05/16 09:44:47 AM
#2151   They most likely sold the shares for tax biotech2010 04/27/16 06:52:36 PM
#2150   Yes it's only about 1.3% of the 10x DirectionalDriller 04/27/16 06:27:58 PM
#2149   And still hold well over 3M shares. Immaterial. Adi2 04/27/16 04:38:50 PM
#2148   The 10x fund sold 44312 shares on April DirectionalDriller 04/27/16 10:43:30 AM
#2147   Interesting chart, thanks for posting it and hopefully biotech2010 04/25/16 09:17:14 AM
#2146   GALT chart Wedge if it completes GALT could dude iligence 04/25/16 12:20:52 AM
#2145   Galmed is working on an oral delivery product IRAHopeful 04/07/16 12:37:53 PM
#2144   I don't post on other boards much but Darwinian 04/07/16 12:23:20 AM
#2143   Presentation: Adi2 03/16/16 07:32:23 AM
#2142   maybe headed to the 100day/av at 1.88.... Chance 03/03/16 07:18:24 AM
#2140   pulm fibrosis patent ? oldsport 02/24/16 11:31:38 AM
#2137   Need to issue more than 500,000 shares just rickyricks 01/26/16 09:04:28 AM
#2136   The stock is a laughingstock. Traber is highly rickyricks 01/26/16 09:00:34 AM
#2135   During this month (Jan, 7 and Jan.21, 2016) JERZYATP1 01/25/16 07:04:38 PM
#2132   Thanks for your thoughtful posts lately JerrzyATP (yes, Darwinian 01/19/16 10:54:17 AM
#2129   As tempting as it is to reiterate why thefamilyman 01/13/16 10:36:57 PM
#2128   Fair enough. In any event the quality of JERZYATP1 01/13/16 10:08:29 PM
#2127   Good for you! Regardless, I sincerely hope thefamilyman 01/11/16 03:37:28 PM
#2126   Musings on executive change (Chairman). As usual a JERZYATP1 01/11/16 03:10:47 PM
#2125   It could be that the BOD has recognized thefamilyman 01/09/16 06:38:11 PM
#2124   I am glad to see the Board of thefamilyman 01/08/16 09:18:41 PM
#2123   Could it be that the flawed leadership I thefamilyman 01/08/16 03:59:33 PM
#2122   A little "house cleaning"/reorg. going on. How much Darwinian 01/08/16 03:21:32 PM
#2121   cool story bro... oldsport 01/05/16 11:56:27 AM